News on ZLB Behring from BioPortfolio.com http://www.BioPortfolio.com Consolidated ZLB Behring news from BioPortfolio.com Wed, 10 Feb 2010 16:40:55 GMT en SWIFT Haemophilia Drug Trials Beginhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028643&HITNO=0&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028643&THISHREF=http://c.moreover.com/click/here.pl%3fz2532796290%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028643&HITNO=0&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028643&THISHREF=http://c.moreover.com/click/here.pl%3fz2532796290%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: Global SWIFT Studies Will Evaluate Safety and Efficacy of CSL Behring's Biostate(R) for von Willebrand Diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019782&HITNO=1&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019782&THISHREF=http://c.moreover.com/click/here.pl%3fz2526477601%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019782&HITNO=1&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019782&THISHREF=http://c.moreover.com/click/here.pl%3fz2526477601%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Global SWIFT unveils new studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020965&HITNO=2&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020965&THISHREF=http://c.moreover.com/click/here.pl%3fz2527075488%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020965&HITNO=2&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020965&THISHREF=http://c.moreover.com/click/here.pl%3fz2527075488%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Europe: von Willebrand disease resourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999826&HITNO=3&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999826&THISHREF=http://c.moreover.com/click/here.pl%3fz2517680528%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999826&HITNO=3&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999826&THISHREF=http://c.moreover.com/click/here.pl%3fz2517680528%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: CSL Behring Launches Berinert(R) Expert Network (B.E.N.(TM)), Support System for Hereditary Angioedema Healthchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987840&HITNO=4&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987840&THISHREF=http://c.moreover.com/click/here.pl%3fz2510137151%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987840&HITNO=4&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987840&THISHREF=http://c.moreover.com/click/here.pl%3fz2510137151%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: CSL Behring launches Berinert Expert Network in USAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981120&HITNO=5&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981120&THISHREF=http://c.moreover.com/click/here.pl%3fz2506783726%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981120&HITNO=5&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981120&THISHREF=http://c.moreover.com/click/here.pl%3fz2506783726%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio Spectrum Asia: CSL Behring Launches Berinert(R) Expert Network (B.E.N.(TM)), Support System for Hereditary Angioedema Healthcare Providers, Patients and Caregivershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971621&HITNO=6&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971621&THISHREF=http://c.moreover.com/click/here.pl%3fz2501937342%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971621&HITNO=6&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971621&THISHREF=http://c.moreover.com/click/here.pl%3fz2501937342%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: CSL Behring Launches Berinert(R) Expert Network (B.E.N.(TM)), Support System for Hereditary Angioedema Healthcare Providers, Patients and Caregivershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971326&HITNO=7&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971326&THISHREF=http://c.moreover.com/click/here.pl%3fz2501810976%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971326&HITNO=7&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971326&THISHREF=http://c.moreover.com/click/here.pl%3fz2501810976%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: CSL Behring Launches Berinert(R) Expert Network (B.E.N.(TM)), Support System for Hereditary Angioedema Healthchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972048&HITNO=8&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972048&THISHREF=http://c.moreover.com/click/here.pl%3fz2502202545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972048&HITNO=8&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972048&THISHREF=http://c.moreover.com/click/here.pl%3fz2502202545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: The Syntax Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962737&HITNO=9&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962737&THISHREF=http://c.moreover.com/click/here.pl%3fz2497442222%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962737&HITNO=9&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962737&THISHREF=http://c.moreover.com/click/here.pl%3fz2497442222%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuropean Hospital: Genzyme Hires Sr. VPhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934162&HITNO=10&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934162&THISHREF=http://c.moreover.com/click/here.pl%3fz2482086443%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934162&HITNO=10&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934162&THISHREF=http://c.moreover.com/click/here.pl%3fz2482086443%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWBJournal.com: Makefield Therapeutics Appoints Jim Ballance CSOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3896605&HITNO=11&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3896605&THISHREF=http://c.moreover.com/click/here.pl%3fz2461848344%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3896605&HITNO=11&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3896605&THISHREF=http://c.moreover.com/click/here.pl%3fz2461848344%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Makefield Therapeutics Appoints Jim Ballance Chief Scientific Officerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3895677&HITNO=12&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3895677&THISHREF=http://c.moreover.com/click/here.pl%3fz2461469033%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3895677&HITNO=12&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3895677&THISHREF=http://c.moreover.com/click/here.pl%3fz2461469033%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Makefield Therapeutics Appoints Jim Ballance Chief Scientific Officerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893973&HITNO=13&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893973&THISHREF=http://c.moreover.com/click/here.pl%3fz2460794907%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893973&HITNO=13&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893973&THISHREF=http://c.moreover.com/click/here.pl%3fz2460794907%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Makefield Therapeutics Appoints Jim Ballance Chief Scientific Officerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893617&HITNO=14&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893617&THISHREF=http://c.moreover.com/click/here.pl%3fz2460662602%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893617&HITNO=14&MSIZE=41&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZLB%20Behring&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893617&THISHREF=http://c.moreover.com/click/here.pl%3fz2460662602%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: